NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ:
Post# of 174
(Total Views: 222)
Posted On: 06/22/2020 3:58:15 PM
NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Building Parallel Network to Healthcare Chains Such as Walgreens or CVS
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, is building a parallel network to healthcare chains such as Walgreens or CVS by bringing together independent pharmacies across the country under its technology and by offering a promise of same-day delivery. The company, which was recently uplisted to Nasdaq, has been bringing together independent pharmacies under one umbrella through its web-based purchasing platform and is now present in all 50 states and rapidly adding 100-150 pharmacies every month. In an interview with AlphaStreet, Trxade CEO Suren Ajjarapu said the company’s focus is to empower independent pharmacies to compete with bigger healthcare retailers such as CVS Health (NYSE: CVS) or Walgreens Boots Alliance (NASDAQ: WBA) by helping them achieve same-day delivery of drugs. “If you look at the telemedicine portals, those scripts are walking into the Walgreens and CVS,” Suren said in the interview. “We want to see whether we can take these scripts to the independents. By giving them business, they will buy more from us. So that’s the strategy.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, is building a parallel network to healthcare chains such as Walgreens or CVS by bringing together independent pharmacies across the country under its technology and by offering a promise of same-day delivery. The company, which was recently uplisted to Nasdaq, has been bringing together independent pharmacies under one umbrella through its web-based purchasing platform and is now present in all 50 states and rapidly adding 100-150 pharmacies every month. In an interview with AlphaStreet, Trxade CEO Suren Ajjarapu said the company’s focus is to empower independent pharmacies to compete with bigger healthcare retailers such as CVS Health (NYSE: CVS) or Walgreens Boots Alliance (NASDAQ: WBA) by helping them achieve same-day delivery of drugs. “If you look at the telemedicine portals, those scripts are walking into the Walgreens and CVS,” Suren said in the interview. “We want to see whether we can take these scripts to the independents. By giving them business, they will buy more from us. So that’s the strategy.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Scienture Holdings, Inc. (SCNX) Stock Research Links
Scroll down for more posts ▼